FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
Go back to FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1107.66 +5.58 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1102.08 | 52 Week High | $88.16 | |||
| Open | $1117.00 | 52 Week Low | $67.88 | |||
| Day High | $1122.02 | P/E | 256.40 | |||
| Day Low | $1079.22 | EPS | $4.32 | |||
| Volume | 2,263,942 | |||||
